Risk of Cardiovascular Events with Rofecoxib

Essay specific features

 

Issue:

Science

 

Written by:

Jean M

 

Date added:

March 11, 2014

 

Level:

University

 

Grade:

A

 

No of pages / words:

5 / 1301

 

Was viewed:

5381 times

 

Rating of current essay:

 
Essay content:

This justifies the withdrawal of rofecoxib from the market. Introduction Rofecoxib is a non-steroidal anti-inflammatory drug (NSAID) which selectively inhibits the cyclooxygenase-2 (COX-2) enzyme.1 It was developed by Merck & Co. for the treatment of acute inflammation in joints, without causing the gastrointestinal side effects associated with traditional NSAIDs...
displayed 300 characters

Custom written essay

All essays are written from scratch by professional writers according to your instructions and delivered to your email on time. Prices start from $10.99/page

Order custom paper

Full essays database

You get access to all the essays and can view as many of them as you like for as little as $28.95/month

Buy database access

Order custom writing paper now!

  • Your research paper is written
    by certified writers
  • Your requirements and targets are
    always met
  • You are able to control the progress
    of your writing assignment
  • You get a chance to become an
    excellent student!

Get a price guote

 
 

2).4 Studies in mice and humans showed that COX-2 is the dominant source of prostaglandin I2, causing vasodilation as well as inhibiting platelet aggregation and vascular proliferation.4 The individual cardiovascular effects of prostaglandin I2 contrast with those of thromboxane A2 ? the major COX-1 product of platelets which cause platelet aggregation, vasoconstriction and vascular proliferation...
displayed 300 characters

General issues of this essay:

Related essays:

x
Services